Cargando…
Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease
Current therapies have not shown benefit in organ damage reversal in Fabry disease (FD), but biomarkers could help risk stratification and prognosis. We investigated if several biomarkers of cardiac fibrosis, cardiac wall stress, myocardial injury, renal function and inflammation, are associated wit...
Autores principales: | Hernández-Romero, Diana, Sánchez-Quiñones, Jessica, Vílchez, Juan Antonio, Rivera-Caravaca, José Miguel, de la Morena, Gonzalo, Lip, Gregory Y. H., Climent, Vicente, Marín, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470309/ https://www.ncbi.nlm.nih.gov/pubmed/30996283 http://dx.doi.org/10.1038/s41598-019-42727-4 |
Ejemplares similares
-
Higher Levels of Galectin-1 and Galectin-3 in Young Subjects with Autism Spectrum Disorder Compared to Unaffected Siblings and Healthy Controls
por: Karadogan, Zeynep Nur, et al.
Publicado: (2023) -
Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
por: Chimenti, Cristina, et al.
Publicado: (2021) -
Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?
por: García-Fernández, Amaya, et al.
Publicado: (2017) -
The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2022) -
Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation
por: Hernández-Romero, Diana, et al.
Publicado: (2017)